Search
Now showing items 1-10 of 35
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
(Massachusetts Medical Society, 2020-03-19)
BACKGROUND: Long-acting injectable regimens may simplify therapy for patients with human immunodeficiency virus type 1 (HIV-1) infection. METHODS: We conducted a phase 3, randomized, open-label trial in which adults with ...
Changes in weight and BMI with first-line doravirine-based therapy.
(2021-01-01)
OBJECTIVE: To evaluate changes in weight and BMI in adults with HIV-1 at 1 and 2 years after starting an antiretroviral regimen that included doravirine, ritonavir-boosted darunavir, or efavirenz. DESIGN: Post-hoc analysis ...
Gender disparities in COVID-19 clinical trial leadership.
(2021-01-05)
OBJECTIVES: We aimed to compare the gender distribution of clinical trial leadership in COVID-19 clinical trials. METHODS: We searched https://clinicaltrials.gov/and retrieved all clinical trials on COVID-19 from January ...